1 |
Yong QD, Jiang SL, Shui BZ, et al (2013). Effect of 5-aza-2'-deoxycytidine on cell proliferation of non small cell lung cancer cell line A549 cells and expression of the TFPI-2 gene. Asian Pac J Cancer Prev, 14, 4421-6.
과학기술학회마을
DOI
ScienceOn
|
2 |
Song Z, Zhang Y (2013). Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib. Mol Clin Oncol, 1, 875-8.
DOI
|
3 |
Vo T TL, Ta BT, Doan MT, et al (2013). Methylation Profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer. Asian Pac J Cancer Prev, 14, 7713-8.
과학기술학회마을
DOI
ScienceOn
|
4 |
Xinbing S, Na K, Minghua Z, et al (2013). Cotargeting EGFR and autophagy signaling: a novel therapeutic strategy for non-small-cell lung cancer. Mol Clin Oncol, 2, 8-12.
|
5 |
Zinn RL, Pruitt K, Eguchi S, et al (2007). hTERT is expressed in cancer cell lines despite promoter DNA methylation by preserbation of unmethylated DNA and active chromatin aroud the transcription start site. Cancer Res, 67, 194-201.
DOI
ScienceOn
|
6 |
Milica Kontic, Jelena Stojsic, Dragana Jovanovic, et al (2012). Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathological characteristics of primary non small cell lung carcinoma. Clin Lung Cancer, 13, 297-303.
DOI
ScienceOn
|
7 |
Blattler A, Farnham PJ (2013). Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem, 288, 34287-94.
DOI
ScienceOn
|
8 |
Jung UL, Hae JS, Ji WS (2012). Promoter Methylation of CDKN2A, , and RASSF1A in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing. Tuberc Respir Dis, 73, 11-21.
DOI
ScienceOn
|
9 |
Linda EC, Thomas J, Prof MT, et al (2009). Molecular predictive and prognostic markers in non-small-cell lung cancer. Lanc Oncol, 10, 1001-10.
DOI
ScienceOn
|
10 |
Nunomiya K, Shibata Y, Abe S, et al (2014). Relationship between serum level of lymphatic vessel endothelial hyaluronan receptor-1 and prognosis in patients with lung cancer. J Cancer, 5, 242-7.
DOI
|
11 |
Pitroda SP, Pashatan M, Logan HL, et al (2014). DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy. Sci Transl Med, 6, 229-42.
|
12 |
Shin HH, Sey EL, Yu TC, et al (2014). Histological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-small cell lung cancer. Mol Clin Oncol, 2, 252-8.
DOI
|
13 |
Qiang L, Junfeng G, Kelong M, et al (2009). RASSF1A, APC, ESR1, ABCB1 and HOXC9, but p16 INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. J Cancer Res Clin Oncol, 135, 1675-84.
DOI
|
14 |
Shicheng G, Lixing T, Weilin P, et al (2014). Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer. Clin Epig, 1, 229-38.
|